0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Leukocyte Antigen Typing and Antibody Testing Market Research Report 2026
Published Date: 2026-04-10
|
Report Code: QYRE-Auto-28Z16893
Home | Market Reports | Science| Biological Sciences
Global Human Leukocyte Antigen Typing and Antibody Testing Market Research Report 2024
BUY CHAPTERS

Global Human Leukocyte Antigen Typing and Antibody Testing Market Research Report 2026

Code: QYRE-Auto-28Z16893
Report
2026-04-10
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Leukocyte Antigen Typing and Antibody Testing Market

The global Human Leukocyte Antigen Typing and Antibody Testing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Human leukocyte antigen (HLA), also known as transplantation antigen, is related to allogeneic tissue and organ transplantation and graft rejection. HLA tissue matching is one of the important factors affecting the survival rate of organ transplantation, hematopoietic stem cell transplantation and the quality of life of the recipient. HLA genes are highly polymorphic and determine the polymorphism of the expressed HLA antigen molecules. Currently, genotyping detection technology is mainly used for HLA typing. Compared with serological and cytological methods, it has higher sensitivity and accuracy and can detect more types.
The North American market for Human Leukocyte Antigen Typing and Antibody Testing is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Human Leukocyte Antigen Typing and Antibody Testing is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Human Leukocyte Antigen Typing and Antibody Testing in Hospital is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Human Leukocyte Antigen Typing and Antibody Testing include Abbott, Siemens, Roche, Thermo Fisher Scientific, Immucor, CareDx, Natera, Eurofins Scientific, Medix Biochemica, GENDX, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Human Leukocyte Antigen Typing and Antibody Testing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Human Leukocyte Antigen Typing and Antibody Testing. The Human Leukocyte Antigen Typing and Antibody Testing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Human Leukocyte Antigen Typing and Antibody Testing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Human Leukocyte Antigen Typing and Antibody Testing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Human Leukocyte Antigen Typing and Antibody Testing Market Report

Report Metric Details
Report Name Human Leukocyte Antigen Typing and Antibody Testing Market
Segment by Type
  • Antigen Typing
  • Antibody Testing
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, Siemens, Roche, Thermo Fisher Scientific, Immucor, CareDx, Natera, Eurofins Scientific, Medix Biochemica, GENDX, CGT Global, Beckman Coulter
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Human Leukocyte Antigen Typing and Antibody Testing companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Human Leukocyte Antigen Typing and Antibody Testing Market report?

Ans: The main players in the Human Leukocyte Antigen Typing and Antibody Testing Market are Abbott, Siemens, Roche, Thermo Fisher Scientific, Immucor, CareDx, Natera, Eurofins Scientific, Medix Biochemica, GENDX, CGT Global, Beckman Coulter

What are the Application segmentation covered in the Human Leukocyte Antigen Typing and Antibody Testing Market report?

Ans: The Applications covered in the Human Leukocyte Antigen Typing and Antibody Testing Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Human Leukocyte Antigen Typing and Antibody Testing Market report?

Ans: The Types covered in the Human Leukocyte Antigen Typing and Antibody Testing Market report are Antigen Typing, Antibody Testing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Leukocyte Antigen Typing and Antibody Testing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Antigen Typing
1.2.3 Antibody Testing
1.3 Market by Application
1.3.1 Global Human Leukocyte Antigen Typing and Antibody Testing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Leukocyte Antigen Typing and Antibody Testing Market Perspective (2021–2032)
2.2 Global Human Leukocyte Antigen Typing and Antibody Testing Growth Trends by Region
2.2.1 Global Human Leukocyte Antigen Typing and Antibody Testing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Human Leukocyte Antigen Typing and Antibody Testing Historic Market Size by Region (2021–2026)
2.2.3 Human Leukocyte Antigen Typing and Antibody Testing Forecasted Market Size by Region (2027–2032)
2.3 Human Leukocyte Antigen Typing and Antibody Testing Market Dynamics
2.3.1 Human Leukocyte Antigen Typing and Antibody Testing Industry Trends
2.3.2 Human Leukocyte Antigen Typing and Antibody Testing Market Drivers
2.3.3 Human Leukocyte Antigen Typing and Antibody Testing Market Challenges
2.3.4 Human Leukocyte Antigen Typing and Antibody Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Leukocyte Antigen Typing and Antibody Testing Players by Revenue
3.1.1 Global Top Human Leukocyte Antigen Typing and Antibody Testing Players by Revenue (2021–2026)
3.1.2 Global Human Leukocyte Antigen Typing and Antibody Testing Revenue Market Share by Players (2021–2026)
3.2 Global Top Human Leukocyte Antigen Typing and Antibody Testing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Human Leukocyte Antigen Typing and Antibody Testing Revenue
3.4 Global Human Leukocyte Antigen Typing and Antibody Testing Market Concentration Ratio
3.4.1 Global Human Leukocyte Antigen Typing and Antibody Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Leukocyte Antigen Typing and Antibody Testing Revenue in 2025
3.5 Global Key Players of Human Leukocyte Antigen Typing and Antibody Testing Head Offices and Areas Served
3.6 Global Key Players of Human Leukocyte Antigen Typing and Antibody Testing, Products and Applications
3.7 Global Key Players of Human Leukocyte Antigen Typing and Antibody Testing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Human Leukocyte Antigen Typing and Antibody Testing Breakdown Data by Type
4.1 Global Human Leukocyte Antigen Typing and Antibody Testing Historic Market Size by Type (2021–2026)
4.2 Global Human Leukocyte Antigen Typing and Antibody Testing Forecasted Market Size by Type (2027–2032)
5 Human Leukocyte Antigen Typing and Antibody Testing Breakdown Data by Application
5.1 Global Human Leukocyte Antigen Typing and Antibody Testing Historic Market Size by Application (2021–2026)
5.2 Global Human Leukocyte Antigen Typing and Antibody Testing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Human Leukocyte Antigen Typing and Antibody Testing Market Size (2021–2032)
6.2 North America Human Leukocyte Antigen Typing and Antibody Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2021–2026)
6.4 North America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Leukocyte Antigen Typing and Antibody Testing Market Size (2021–2032)
7.2 Europe Human Leukocyte Antigen Typing and Antibody Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2021–2026)
7.4 Europe Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Market Size (2021–2032)
8.2 Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Market Size by Region (2021–2026)
8.4 Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Human Leukocyte Antigen Typing and Antibody Testing Market Size (2021–2032)
9.2 Latin America Human Leukocyte Antigen Typing and Antibody Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2021–2026)
9.4 Latin America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Leukocyte Antigen Typing and Antibody Testing Market Size (2021–2032)
10.2 Middle East & Africa Human Leukocyte Antigen Typing and Antibody Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2021–2026)
10.4 Middle East & Africa Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.1.4 Abbott Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
11.1.5 Abbott Recent Development
11.2 Siemens
11.2.1 Siemens Company Details
11.2.2 Siemens Business Overview
11.2.3 Siemens Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.2.4 Siemens Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
11.2.5 Siemens Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.3.4 Roche Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
11.3.5 Roche Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Immucor
11.5.1 Immucor Company Details
11.5.2 Immucor Business Overview
11.5.3 Immucor Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.5.4 Immucor Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
11.5.5 Immucor Recent Development
11.6 CareDx
11.6.1 CareDx Company Details
11.6.2 CareDx Business Overview
11.6.3 CareDx Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.6.4 CareDx Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
11.6.5 CareDx Recent Development
11.7 Natera
11.7.1 Natera Company Details
11.7.2 Natera Business Overview
11.7.3 Natera Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.7.4 Natera Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
11.7.5 Natera Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Details
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.8.4 Eurofins Scientific Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
11.8.5 Eurofins Scientific Recent Development
11.9 Medix Biochemica
11.9.1 Medix Biochemica Company Details
11.9.2 Medix Biochemica Business Overview
11.9.3 Medix Biochemica Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.9.4 Medix Biochemica Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
11.9.5 Medix Biochemica Recent Development
11.10 GENDX
11.10.1 GENDX Company Details
11.10.2 GENDX Business Overview
11.10.3 GENDX Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.10.4 GENDX Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
11.10.5 GENDX Recent Development
11.11 CGT Global
11.11.1 CGT Global Company Details
11.11.2 CGT Global Business Overview
11.11.3 CGT Global Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.11.4 CGT Global Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
11.11.5 CGT Global Recent Development
11.12 Beckman Coulter
11.12.1 Beckman Coulter Company Details
11.12.2 Beckman Coulter Business Overview
11.12.3 Beckman Coulter Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.12.4 Beckman Coulter Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
11.12.5 Beckman Coulter Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Antigen Typing
 Table 3. Key Players of Antibody Testing
 Table 4. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Human Leukocyte Antigen Typing and Antibody Testing Market Share by Region (2021–2026)
 Table 8. Global Human Leukocyte Antigen Typing and Antibody Testing Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Human Leukocyte Antigen Typing and Antibody Testing Market Share by Region (2027–2032)
 Table 10. Human Leukocyte Antigen Typing and Antibody Testing Market Trends
 Table 11. Human Leukocyte Antigen Typing and Antibody Testing Market Drivers
 Table 12. Human Leukocyte Antigen Typing and Antibody Testing Market Challenges
 Table 13. Human Leukocyte Antigen Typing and Antibody Testing Market Restraints
 Table 14. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Human Leukocyte Antigen Typing and Antibody Testing Market Share by Players (2021–2026)
 Table 16. Global Top Human Leukocyte Antigen Typing and Antibody Testing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Human Leukocyte Antigen Typing and Antibody Testing Revenue, 2025
 Table 17. Ranking of Global Top Human Leukocyte Antigen Typing and Antibody Testing Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Human Leukocyte Antigen Typing and Antibody Testing Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Human Leukocyte Antigen Typing and Antibody Testing, Headquarters and Area Served
 Table 20. Global Key Players of Human Leukocyte Antigen Typing and Antibody Testing, Products and Applications
 Table 21. Global Key Players of Human Leukocyte Antigen Typing and Antibody Testing, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue Market Share by Type (2021–2026)
 Table 25. Global Human Leukocyte Antigen Typing and Antibody Testing Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue Market Share by Type (2027–2032)
 Table 27. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue Market Share by Application (2021–2026)
 Table 29. Global Human Leukocyte Antigen Typing and Antibody Testing Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue Market Share by Application (2027–2032)
 Table 31. North America Human Leukocyte Antigen Typing and Antibody Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Human Leukocyte Antigen Typing and Antibody Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Human Leukocyte Antigen Typing and Antibody Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Human Leukocyte Antigen Typing and Antibody Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (US$ Million), 2027–2032
 Table 46. Abbott Company Details
 Table 47. Abbott Business Overview
 Table 48. Abbott Human Leukocyte Antigen Typing and Antibody Testing Product
 Table 49. Abbott Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (US$ Million), 2021–2026
 Table 50. Abbott Recent Development
 Table 51. Siemens Company Details
 Table 52. Siemens Business Overview
 Table 53. Siemens Human Leukocyte Antigen Typing and Antibody Testing Product
 Table 54. Siemens Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (US$ Million), 2021–2026
 Table 55. Siemens Recent Development
 Table 56. Roche Company Details
 Table 57. Roche Business Overview
 Table 58. Roche Human Leukocyte Antigen Typing and Antibody Testing Product
 Table 59. Roche Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (US$ Million), 2021–2026
 Table 60. Roche Recent Development
 Table 61. Thermo Fisher Scientific Company Details
 Table 62. Thermo Fisher Scientific Business Overview
 Table 63. Thermo Fisher Scientific Human Leukocyte Antigen Typing and Antibody Testing Product
 Table 64. Thermo Fisher Scientific Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (US$ Million), 2021–2026
 Table 65. Thermo Fisher Scientific Recent Development
 Table 66. Immucor Company Details
 Table 67. Immucor Business Overview
 Table 68. Immucor Human Leukocyte Antigen Typing and Antibody Testing Product
 Table 69. Immucor Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (US$ Million), 2021–2026
 Table 70. Immucor Recent Development
 Table 71. CareDx Company Details
 Table 72. CareDx Business Overview
 Table 73. CareDx Human Leukocyte Antigen Typing and Antibody Testing Product
 Table 74. CareDx Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (US$ Million), 2021–2026
 Table 75. CareDx Recent Development
 Table 76. Natera Company Details
 Table 77. Natera Business Overview
 Table 78. Natera Human Leukocyte Antigen Typing and Antibody Testing Product
 Table 79. Natera Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (US$ Million), 2021–2026
 Table 80. Natera Recent Development
 Table 81. Eurofins Scientific Company Details
 Table 82. Eurofins Scientific Business Overview
 Table 83. Eurofins Scientific Human Leukocyte Antigen Typing and Antibody Testing Product
 Table 84. Eurofins Scientific Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (US$ Million), 2021–2026
 Table 85. Eurofins Scientific Recent Development
 Table 86. Medix Biochemica Company Details
 Table 87. Medix Biochemica Business Overview
 Table 88. Medix Biochemica Human Leukocyte Antigen Typing and Antibody Testing Product
 Table 89. Medix Biochemica Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (US$ Million), 2021–2026
 Table 90. Medix Biochemica Recent Development
 Table 91. GENDX Company Details
 Table 92. GENDX Business Overview
 Table 93. GENDX Human Leukocyte Antigen Typing and Antibody Testing Product
 Table 94. GENDX Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (US$ Million), 2021–2026
 Table 95. GENDX Recent Development
 Table 96. CGT Global Company Details
 Table 97. CGT Global Business Overview
 Table 98. CGT Global Human Leukocyte Antigen Typing and Antibody Testing Product
 Table 99. CGT Global Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (US$ Million), 2021–2026
 Table 100. CGT Global Recent Development
 Table 101. Beckman Coulter Company Details
 Table 102. Beckman Coulter Business Overview
 Table 103. Beckman Coulter Human Leukocyte Antigen Typing and Antibody Testing Product
 Table 104. Beckman Coulter Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (US$ Million), 2021–2026
 Table 105. Beckman Coulter Recent Development
 Table 106. Research Programs/Design for This Report
 Table 107. Key Data Information from Secondary Sources
 Table 108. Key Data Information from Primary Sources
 Table 109. Authors List of This Report


List of Figures
 Figure 1. Human Leukocyte Antigen Typing and Antibody Testing Picture
 Figure 2. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Human Leukocyte Antigen Typing and Antibody Testing Market Share by Type: 2025 vs 2032
 Figure 4. Antigen Typing Features
 Figure 5. Antibody Testing Features
 Figure 6. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Human Leukocyte Antigen Typing and Antibody Testing Market Share by Application: 2025 vs 2032
 Figure 8. Hospital Case Studies
 Figure 9. Clinic Case Studies
 Figure 10. Other Case Studies
 Figure 11. Human Leukocyte Antigen Typing and Antibody Testing Report Years Considered
 Figure 12. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 13. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Human Leukocyte Antigen Typing and Antibody Testing Market Share by Region: 2025 vs 2032
 Figure 15. Global Human Leukocyte Antigen Typing and Antibody Testing Market Share by Players in 2025
 Figure 16. Global Human Leukocyte Antigen Typing and Antibody Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 17. The Top 10 and 5 Players Market Share by Human Leukocyte Antigen Typing and Antibody Testing Revenue in 2025
 Figure 18. North America Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 19. North America Human Leukocyte Antigen Typing and Antibody Testing Market Share by Country (2021–2032)
 Figure 20. United States Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Canada Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Human Leukocyte Antigen Typing and Antibody Testing Market Share by Country (2021–2032)
 Figure 24. Germany Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. France Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. U.K. Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Italy Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Russia Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Ireland Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Market Share by Region (2021–2032)
 Figure 32. China Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Japan Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. South Korea Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Southeast Asia Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. India Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Australia & New Zealand Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Human Leukocyte Antigen Typing and Antibody Testing Market Share by Country (2021–2032)
 Figure 40. Mexico Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Brazil Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Human Leukocyte Antigen Typing and Antibody Testing Market Share by Country (2021–2032)
 Figure 44. Israel Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Saudi Arabia Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. UAE Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Abbott Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
 Figure 48. Siemens Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
 Figure 49. Roche Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
 Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
 Figure 51. Immucor Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
 Figure 52. CareDx Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
 Figure 53. Natera Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
 Figure 54. Eurofins Scientific Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
 Figure 55. Medix Biochemica Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
 Figure 56. GENDX Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
 Figure 57. CGT Global Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
 Figure 58. Beckman Coulter Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2021–2026)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI